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dilatation of a targeted coronary stenosis (stenoses) such that the residual luminal narrowing was less than 40% and not associated with complications.
Study design
This was a retrospective cohort study that was carried out at a single centre, the Royal Prince Alfred Hospital in Sidney. The length of follow-up was not reported. Data were available for all patients. The outcomes were estimated from the coronary artery surgery register at the study hospital.
Analysis of effectiveness
All of the patients included in the initial study sample were accounted for in the analysis of effectiveness. The outcome measures used were: preoperative procedures and degree of coronary artery disease; several postoperative criteria, including intra-aortic balloon pump, low cardiac output syndrome, prolonged ventilation, dialysis, haemorrhage greater than 1.5 L, neurological injury, wound infection, myocardial infarction, atrial fibrillation and ventricular fibrillation;
30-day mortality; and
the length of hospital stay.
At baseline, the study groups were comparable in terms of the incidence of major medical co-morbidities or coronary artery disease factors. However, the control group had a slightly greater proportion of male patients than the interval group (80% versus 75%; p<0.05) and a lower mean preoperative left ventricular ejection fraction (0.56 versus 0.65; p<0.05). In addition, a greater proportion of patients in the control group were classified as obese (47% versus 33%; p<0.05) and had a history of smoking (67% versus 60%; p<0.05) compared with the interval group. A significantly higher number of patients in the interval population presented for CABG with unstable angina pectoris (70% versus 52%; p<0.05).
Effectiveness results
In the interval group, the mean number of coronary angiograms per patient was 1.7 (median 1; range: 1 -5) and the mean number of PTCAs per patient was 1.2 (median 1; range: 1 -4).
The mean interval from initial PTCA to graft surgery was 13.7 months (range: 1 day -149 months) and the median interval was 4 months.
The time interval decreased over the study period (17 years).
The degree of coronary artery disease differed between groups: preoperative angiography revealed a greater proportion of patients in the control group with triple-vessel coronary advanced ischaemic pathology in comparison with the interval group; control patients had a mean of 2.6 systems with significant atherosclerotic disease, compared with 2 vessels in the interval group, (p<0.05); control patients also had greater than 50% stenosis on the left main coronary artery; the mean number of distal anastomoses was 2.9 (range: 1 -8) in the interval group and 4.1 (range: 1 -8) in the control group, (p<0.05); and the mean cardiopulmonary bypass time was 65 minutes (range: 16 -181) in the interval group and 85.3 minutes (range: None of the differences in terms of postoperative criteria reached statistical significance. The rate of 30-day mortality was 2% in both groups.
The mean hospital stay was 8 days (range: 1 -49) in the interval group and 9.1 days (range: 0 -99) in the control group, (p<0.05).
Clinical conclusions
The effectiveness analysis showed that the two groups were comparable in terms of effectiveness and safety profile. A longer hospital stay was observed in the control patients.
Measure of benefits used in the economic analysis
No summary benefit measure was used in the economic analysis because the two groups of patients were comparable with respect to clinical outcomes. In effect, a cost-minimisation analysis appears to have been performed.
Direct costs
Discounting was not relevant since the costs per patient were generally incurred during less than 2 years. The unit costs were not presented separately from the quantities of resources used. The economic evaluation considered all hospital costs associated with coronary angiography, PTCA and CABG (with and without complications). The cost/resource boundary of the study was not reported clearly but it could have been that of the hospital. Resource use was estimated using data derived from the sample of patients included in the clinical study. CABG (with or without complications) also included the cost of one diagnostic angiogram, while the costs in the interval group included a mean of 1.7 angiograms, 1.2 PTCA procedures, and 1 CABG (with or without complications). No stents were used. The costs came from diagnosis-related group (DRG) data, which were estimated at the study hospital. The costs were estimated using 1995-1996 prices.
